The best compounded GLP‑1 programs (8 compared)
The best compounded GLP-1 programs online, ranked on verified price, fees, pharmacy and FDA warning letters. Compare semaglutide and tirzepatide plans.
Ranked on our rating, then on programs built around compounded medication. Never on commission: the order is the same whether a program pays us or not.
The best pick for what you need
- No FDA warning letter
- Names its pharmacy
- Prices checked Oct 26, 2026
Lttl sells compounded semaglutide and tirzepatide as weekly injections, lower-dose microdose plans of both, and a separate menu of compounded longevity products: NAD+ (injection, nasal spray or oral liquid), sermorelin, glutathione, MIC+B12, L-carnitine and methylene blue. Its terms name four pharmacies that may fill orders, and its launch release says they are 503A pharmacies. Semaglutide is $99 and tirzepatide $149 for a 4-week supply on the monthly plan, or $89 and $139 a month on a 12-month plan billed up front. If you have side effects, talk to your provider.
Lttl has no FDA warning letter on file; Triad Rx had one in 2019, closed out in 2023, and Red Rock's Springville, Utah site received a Form 483 in July 2026 (Lttl lists its St. George site); it says it serves all 50 states and DC.
- No FDA warning letter
- Names its pharmacy
- LegitScript certified
- Prices checked Oct 26, 2026
Embody sells two compounded drugs, semaglutide and tirzepatide, both weekly injections, and names the four 503A pharmacies that fill them: Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. In its Black Friday sale until December 1, 2026, semaglutide is $49 and tirzepatide $99 a month on a 12-month plan, billed $588 and $1,188 up front and not refunded, with the medication, the doctor review and shipping included; month to month they are $99 and $149, and 3- and 6-month plans cost $89 and $79 for semaglutide, or $139 and $129 for tirzepatide. Only commit to a year if you plan to stay on the drug that long, and if you have side effects, talk to your provider.
Embody has no FDA warning letter on file; Triad Rx had one in 2019, closed out in 2023, and Red Rock's Springville, Utah site received a Form 483 in July 2026; ships to every state except Louisiana.
- No FDA warning letter
- Names its pharmacy
- LegitScript certified
- Prices checked Oct 26, 2026
YourEra sells compounded semaglutide at $89 a month and compounded tirzepatide at $129 a month, both weekly injections month to month at any dose, plus microdosing plans and NAD+. Its terms name the three pharmacies that fill orders: Galleria Medical Pharmacy, which YourEra manages, MediVera Compounding Pharmacy and VialsRx, without saying whether they are 503A or 503B. There is no membership fee, and you get a full refund if you cancel before your order ships.
No FDA warning letter on file for YourEra; MediVera's parent, Diversified Pharmacy, had one in 2016 that the FDA closed out in 2018; LegitScript certified; all 50 states, with treatments that vary by state.
- No FDA warning letter
- LegitScript certified
- Prices checked Oct 26, 2026
Collective sells compounded semaglutide at $59 a month and compounded tirzepatide at $69 a month, both weekly injections at the same price at any dose, plus a required $199 annual membership. It does not name the pharmacy that makes them or say whether it is 503A or 503B, saying only that orders are filled by a state-licensed US pharmacy and every batch is third-party tested. The membership is charged after a 21-day free trial and is not refunded, so take it only if you expect to stay on treatment; if you have side effects, talk to your provider.
No FDA warning letter on file; the pharmacy is unnamed, so its record can't be checked; 44 states, not Alabama, California, Louisiana, Massachusetts, Mississippi or Washington.
- No FDA warning letter
- Names its pharmacy
- LegitScript certified
- Prices checked Oct 26, 2026
Enhanced sells compounded semaglutide and compounded tirzepatide as weekly injections, plus lower-dose microdosed plans of both. Its FAQ names four partner pharmacies, Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx, but not which one fills your order, and says only that the drug comes from "a licensed 503A/503B pharmacy". Month to month, semaglutide is $129 and tirzepatide $169; the 12-month plans are $89 and $129 a month, charged in full at checkout. If you have side effects, talk to your provider.
Enhanced has no FDA warning letter on file and LegitScript lists enhanced.com as certified; Triad Rx had one in 2019, closed out in 2023; care comes from independent telehealth providers identified at intake, and Enhanced publishes no list of states.
- No FDA warning letter
- LegitScript certified
- Prices checked Oct 26, 2026
HealthRX sells compounded semaglutide and compounded tirzepatide, both weekly injections from a 503A pharmacy it does not name. On the monthly Subscribe & Save plan, each costs $99 for the first month, then $165 a month for semaglutide or $214 for tirzepatide, with the medication, the clinician review and overnight shipping included. Prepaid 3-, 6- and 12-month plans lower the monthly rate to as little as $97 and $177; prepay only if you plan to stay that long, and if you have side effects, talk to your provider.
Its own pages say it doesn't own a pharmacy and that orders are compounded by a licensed 503A pharmacy, which it doesn't name; no FDA warning letter on file; LegitScript certified (#50087439); all 50 states.
- No FDA warning letter
- Prices checked Oct 20, 2026
Live Vital sells compounded semaglutide and compounded tirzepatide as weekly injections, each as a prepaid 3-month supply at checkout: $299 for semaglutide, about $100 a month, and $549 for tirzepatide, $183 a month; the public drug pages call the same price a 10-week protocol. Both sit on a menu of other compounded peptides, and its FAQ says the drug comes from a 503A pharmacy, which it does not name, while its weight-loss guide says 503B. There is no month-to-month plan, and medication is generally not refunded once compounded or shipped, so pay for a supply only if you plan to finish it; if you have side effects, talk to your provider.
A Utah practice led by Dr. Patrick Taylor, MD; no FDA warning letter on file; the pharmacy is unnamed, so its record can't be checked; its states page lists all 50 states; HSA and FSA funds are accepted.
- No FDA warning letter
- LegitScript certified
- Prices checked Oct 26, 2026
bmiMD sells compounded semaglutide and compounded tirzepatide as weekly injections, each also as a microdose program, with the physician visit, the medication and shipping in one price at any dose. Month to month, semaglutide is $159 and tirzepatide $249; on a 12-month plan they are $119 and $179 a month. It does not name its pharmacy or its type, saying only that orders ship from a US-based licensed partner pharmacy. Multi-month plans can't be refunded once your first order goes to the pharmacy, so commit only if you will stay; if you have side effects, talk to your provider.
Board-certified physicians do a usually same-day telehealth consult; no FDA warning letter on file; the pharmacy is unnamed, so its record can't be checked; all 50 states.
“From” prices are the lowest verified rate on the program’s own checkout, usually a prepaid plan. Reference only: we don’t sell medication, we verify who does.
Our top picks, in short
- #1
Lttl — from $89 a month, best for users who want one price at every dose, no membership fee, and the pharmacies named up front. - #2
Embody — from $49 a month, best for users who want the lowest all-in price on compounded semaglutide or tirzepatide, with no membership fee and round-the-clock specialist support. - #3
YourEra — from $65 a month.
Compounded GLP‑1 programs: what people ask
How this ranking works
- How we score
- Every program is scored 0–10 on verified price, transparency and the safety record.
- What removes a program
- An open FDA warning letter removes a program from every recommendation on this site.
- How we make money
- Some outbound links are affiliate links. Commission is not an input to a score, and a program cannot pay to change it.